FDA accepts New Drug Application for Fibromyalgia
As I discussed in a previous post entitled “Just another stab in the dark -or- potential effective drug”, the drug GHB has been in the news recently as a potential treatment for chronic pain, specifically stemming from Fibromyalgia.
The FDA has now accepted the filing of a New Drug Application for this drug, officially known as Sodium Oxybate, as a potential pharmaceutical treatment for Fibromyalgia.
It will be under a review process, but it is believed that this drug relieves pain and fatigue, and restores sleep better than Lyrica, another drug that is currently FDA approved for the treatment of this illness.
Interestingly enough, Jazz Pharmaceuticals, the company that has filed the New Drug Application, had a rise on the stock market yesterday. After announcing the filing with the FDA, shares in this company increased by 51 percent. Health is big business people!!
In trials so far, this medication has brought down overall pain levels by approx 30 percent… Would that be enough for you to try it?
It’ll be interesting to see where this goes, and how this will affect the Chronic Pain Community!!
What are your feelings? I’d love to hear from you!!